171 related articles for article (PubMed ID: 28352901)
1. Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.
Bateman LA; Nguyen TB; Roberts AM; Miyamoto DK; Ku WM; Huffman TR; Petri Y; Heslin MJ; Contreras CM; Skibola CF; Olzmann JA; Nomura DK
Chem Commun (Camb); 2017 Jun; 53(53):7234-7237. PubMed ID: 28352901
[TBL] [Abstract][Full Text] [Related]
2. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.
Roberts AM; Miyamoto DK; Huffman TR; Bateman LA; Ives AN; Akopian D; Heslin MJ; Contreras CM; Rape M; Skibola CF; Nomura DK
ACS Chem Biol; 2017 Apr; 12(4):899-904. PubMed ID: 28186401
[TBL] [Abstract][Full Text] [Related]
3. Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.
Counihan JL; Wiggenhorn AL; Anderson KE; Nomura DK
ACS Chem Biol; 2018 Aug; 13(8):1970-1977. PubMed ID: 30004670
[TBL] [Abstract][Full Text] [Related]
4. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.
Grossman EA; Ward CC; Spradlin JN; Bateman LA; Huffman TR; Miyamoto DK; Kleinman JI; Nomura DK
Cell Chem Biol; 2017 Nov; 24(11):1368-1376.e4. PubMed ID: 28919038
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane protein TMEM170A is a newly discovered regulator of ER and nuclear envelope morphogenesis in human cells.
Christodoulou A; Santarella-Mellwig R; Santama N; Mattaj IW
J Cell Sci; 2016 Apr; 129(8):1552-65. PubMed ID: 26906412
[TBL] [Abstract][Full Text] [Related]
6. Cell fate regulation by reticulon-4 in human prostate cancers.
Zhao H; Su W; Zhu C; Zeng T; Yang S; Wu W; Wang D
J Cell Physiol; 2019 Jul; 234(7):10372-10385. PubMed ID: 30480803
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of reticulon 4C by lentivirus inhibits human colorectal cancer cell growth.
Xue H; Wang Z; Chen J; Yang Z; Tang J
Mol Med Rep; 2015 Aug; 12(2):2063-7. PubMed ID: 25847052
[TBL] [Abstract][Full Text] [Related]
8. Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity.
Anderson KE; To M; Olzmann JA; Nomura DK
ACS Chem Biol; 2017 Oct; 12(10):2522-2528. PubMed ID: 28892616
[TBL] [Abstract][Full Text] [Related]
9. Mapping Novel Metabolic Nodes Targeted by Anti-Cancer Drugs that Impair Triple-Negative Breast Cancer Pathogenicity.
Roberts LS; Yan P; Bateman LA; Nomura DK
ACS Chem Biol; 2017 Apr; 12(4):1133-1140. PubMed ID: 28248089
[TBL] [Abstract][Full Text] [Related]
10. Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB.
King EA; Cho Y; Hsu NS; Dovala D; McKenna JM; Tallarico JA; Schirle M; Nomura DK
Cell Chem Biol; 2023 Apr; 30(4):394-402.e9. PubMed ID: 36898369
[TBL] [Abstract][Full Text] [Related]
11. The nanoscale organization of reticulon 4 shapes local endoplasmic reticulum structure in situ.
Fuentes LA; Marin Z; Tyson J; Baddeley D; Bewersdorf J
J Cell Biol; 2023 Oct; 222(10):. PubMed ID: 37516910
[TBL] [Abstract][Full Text] [Related]
12. Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity.
Bateman LA; Ku WM; Heslin MJ; Contreras CM; Skibola CF; Nomura DK
ACS Chem Biol; 2017 Apr; 12(4):905-911. PubMed ID: 28229591
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic Reticulum Tubule Protein Reticulon 4 Associates with the Legionella pneumophila Vacuole and with Translocated Substrate Ceg9.
Haenssler E; Ramabhadran V; Murphy CS; Heidtman MI; Isberg RR
Infect Immun; 2015 Sep; 83(9):3479-89. PubMed ID: 26099580
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ER Composition and Extent, and Putative Action in Protein Networks by ER/NE Protein TMEM147.
Maimaris G; Christodoulou A; Santama N; Lederer CW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638576
[TBL] [Abstract][Full Text] [Related]
15. Reactive-cysteine profiling for drug discovery.
Maurais AJ; Weerapana E
Curr Opin Chem Biol; 2019 Jun; 50():29-36. PubMed ID: 30897495
[TBL] [Abstract][Full Text] [Related]
16. NOGO-A/RTN4A and NOGO-B/RTN4B are simultaneously expressed in epithelial, fibroblast and neuronal cells and maintain ER morphology.
Rämö O; Kumar D; Gucciardo E; Joensuu M; Saarekas M; Vihinen H; Belevich I; Smolander OP; Qian K; Auvinen P; Jokitalo E
Sci Rep; 2016 Oct; 6():35969. PubMed ID: 27786289
[TBL] [Abstract][Full Text] [Related]
17. RTN4/NoGo-receptor binding to BAI adhesion-GPCRs regulates neuronal development.
Wang J; Miao Y; Wicklein R; Sun Z; Wang J; Jude KM; Fernandes RA; Merrill SA; Wernig M; Garcia KC; Südhof TC
Cell; 2021 Nov; 184(24):5869-5885.e25. PubMed ID: 34758294
[TBL] [Abstract][Full Text] [Related]
18. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
19. AzidoTMT Enables Direct Enrichment and Highly Multiplexed Quantitation of Proteome-Wide Functional Residues.
Ma TP; Izrael-Tomasevic A; Mroue R; Budayeva H; Malhotra S; Raisner R; Evangelista M; Rose CM; Kirkpatrick DS; Yu K
J Proteome Res; 2023 Jul; 22(7):2218-2231. PubMed ID: 37285454
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome.
Rao S; Gurbani D; Du G; Everley RA; Browne CM; Chaikuad A; Tan L; Schröder M; Gondi S; Ficarro SB; Sim T; Kim ND; Berberich MJ; Knapp S; Marto JA; Westover KD; Sorger PK; Gray NS
Cell Chem Biol; 2019 Jun; 26(6):818-829.e9. PubMed ID: 30982749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
